SV2A and Alzheimer disease: 18F-fluorodeoxyglucose (FDG) PET Is helpful in both dementia and epilepsy but has not yet been evaluated in AD-related epilepsy. Can detect altered synaptic vesicle glycoprotein 2A and altered adenosine receptor expression, derangements of both are seen in various neurological disorders [52-54].